OSD
Reducing timelines to market to deliver vital medicines to patients at accelerated rates is a shared goal across the pharmaceutical industry. Providing insight into product properties and assuring quality, analytical testing methods are at the core of drug development and manufacturing, with optimised analytics helping to drive efficiency and streamline production pipelines.
Technological innovation provides the tools to drive efficiency, transforming analytical testing approaches. The integration of robotics enables process automation and reduces reliance on manual input, speeding up operations and increasing accuracy. For example, upon elution from chromatography systems, samples can be seamlessly tested by implementing autosampler technology. With automated sampling, productivity and consistency increase, and the risk of sample contamination is reduced. Automated processes can also be monitored remotely, providing visibility. When using automation combined with artificial intelligence (AI), any deviations from ideal conditions could be detected and real-time corrections could be implemented without manual input.
The increasing interest in complex modalities, such as personalised medicine, demands advanced instrumentation and specialised methods. This is a result of currently established techniques often needing to be more compatible with new therapeutics. With technological advances driving robust analytical workflows, tailor-made solutions can be effectively designed to ensure high-quality drug products are formed at speed.
In an article featured in Drug Development & Delivery, Ramesh Jagadeesan, Vice President, Analytical Development at Recipharm, explores how technological advances are changing current analytical testing approaches to streamline drug development and manufacturing for the accelerated delivery of essential treatments to patients.